GlassScriptPhysician profile
Timothy Michael Phelan
NPI 1639131584
$1,104.87
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $293 · 2021: $42.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.35 | 2019-2020 | |
| Amgen INC. | $127.36 | 2019-2020 | |
| Therapeuticsmd, INC. | $85.42 | 2019-2020 | |
| Minerva Surgical, INC | $83.34 | 2019 | |
| Lupin INC. | $72.50 | 2019-2020 | |
| Hologic Sales and Service, LLC | $66.82 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.71 | 2019-2020 | |
| Evofem Biosciences, INC. | $42.65 | 2021 | |
| Millicent US INC | $36.96 | 2019-2020 | |
| Aspira Women'S Health INC | $26.02 | 2020 | |
| Daiichi Sankyo INC. | $20.85 | 2019 | |
| Pfizer INC. | $15.76 | 2019 | |
| Mission Pharmacal Company | $15.38 | 2019 | |
| Apollo Endosurgery US INC | $12.90 | 2019 | |
| Allergan, INC. | $12.08 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $11.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Phelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.